Clinical Trial Update: Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Balcinrenone and Dapagliflozin in patients with heart failure and impaired kidney function is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Balcinrenone
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure and Impaired Kidney Function | Phase 3 | Status: RECRUITING